NO20014725L - Forbedret kreftbehandling med temozolomid - Google Patents

Forbedret kreftbehandling med temozolomid

Info

Publication number
NO20014725L
NO20014725L NO20014725A NO20014725A NO20014725L NO 20014725 L NO20014725 L NO 20014725L NO 20014725 A NO20014725 A NO 20014725A NO 20014725 A NO20014725 A NO 20014725A NO 20014725 L NO20014725 L NO 20014725L
Authority
NO
Norway
Prior art keywords
temozolomide
cancer treatment
enhanced cancer
enhanced
treatment
Prior art date
Application number
NO20014725A
Other languages
English (en)
Other versions
NO20014725D0 (no
NO330651B1 (no
Inventor
Mohamed H Ragab
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20014725D0 publication Critical patent/NO20014725D0/no
Publication of NO20014725L publication Critical patent/NO20014725L/no
Publication of NO330651B1 publication Critical patent/NO330651B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20014725A 1999-03-30 2001-09-28 Anvendelse av temozolomid til fremstilling av et preparat mot kreft NO330651B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28134899A 1999-03-30 1999-03-30
PCT/US2000/008079 WO2000057867A2 (en) 1999-03-30 2000-03-27 Improved cancer treatment with temozolomide

Publications (3)

Publication Number Publication Date
NO20014725D0 NO20014725D0 (no) 2001-09-28
NO20014725L true NO20014725L (no) 2001-11-13
NO330651B1 NO330651B1 (no) 2011-05-30

Family

ID=23076905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014725A NO330651B1 (no) 1999-03-30 2001-09-28 Anvendelse av temozolomid til fremstilling av et preparat mot kreft

Country Status (18)

Country Link
EP (1) EP1165071B1 (no)
JP (2) JP2002540148A (no)
CN (2) CN1345240A (no)
AR (1) AR023185A1 (no)
AT (1) ATE310515T1 (no)
AU (1) AU780892B2 (no)
BR (1) BR0009380A (no)
CA (1) CA2368614C (no)
DE (1) DE60024243T2 (no)
DK (1) DK1165071T3 (no)
ES (1) ES2251987T3 (no)
HK (1) HK1044111B (no)
HU (1) HUP0200805A3 (no)
NO (1) NO330651B1 (no)
NZ (1) NZ536302A (no)
TW (1) TWI276434B (no)
WO (1) WO2000057867A2 (no)
ZA (1) ZA200107736B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100366249C (zh) 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药***
CN1742723A (zh) * 2004-09-02 2006-03-08 天津倍方科技发展有限公司 含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途
CN1299772C (zh) * 2004-10-14 2007-02-14 孔庆忠 一种抗癌药物组合物
AU2005304672B2 (en) * 2004-11-09 2010-03-11 Schering Corporation Improved dosing regimen of temozolomide for treating cancer based on the patient's MGMT level
EP2329818A1 (en) * 2006-01-17 2011-06-08 Abbott Laboratories Combination therapy with PARP inhibitors
US7563801B2 (en) * 2006-04-05 2009-07-21 Schering Corporation Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
AR061618A1 (es) * 2006-06-26 2008-09-10 Schering Corp Formas de dosificacion unitaria de temozolomida
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
NZ575636A (en) * 2006-09-29 2012-02-24 Cipla Ltd An improved process for the preparation of temozolomide and analogs
US20140005160A1 (en) * 2010-12-01 2014-01-02 Hooshmand SHESHBARADARAN Method for Treating Refractory Cancer
CN102526038B (zh) * 2011-01-12 2013-09-11 北京人福军威医药技术开发有限公司 替莫唑胺的脑靶向药物组合物及其应用
CN107397735B (zh) * 2017-07-28 2020-07-10 东曜药业有限公司 一种替莫唑胺药物组合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU719074B2 (en) * 1995-10-04 2000-05-04 Schering Corporation Combination of temozolomide and alpha-IFN for the treatment of advanced cancer
CA2184545A1 (en) * 1996-07-31 1998-02-01 Pascale Reidenberg Cancer treatment with temozolomide
CA2184546A1 (en) * 1996-07-31 1998-02-01 Margaret H. Dugan Method for treating pediatric high grade astrocytoma including brain stem glioma

Also Published As

Publication number Publication date
CA2368614A1 (en) 2000-10-05
EP1165071B1 (en) 2005-11-23
JP2002540148A (ja) 2002-11-26
CN102160864A (zh) 2011-08-24
HK1044111B (zh) 2006-02-24
EP1165071A2 (en) 2002-01-02
NZ536302A (en) 2006-05-26
HUP0200805A2 (hu) 2002-07-29
NO20014725D0 (no) 2001-09-28
BR0009380A (pt) 2001-12-26
WO2000057867A2 (en) 2000-10-05
AU780892B2 (en) 2005-04-21
CA2368614C (en) 2008-07-22
WO2000057867A3 (en) 2001-04-19
NO330651B1 (no) 2011-05-30
ES2251987T3 (es) 2006-05-16
DE60024243T2 (de) 2006-08-17
AR023185A1 (es) 2002-09-04
ATE310515T1 (de) 2005-12-15
HUP0200805A3 (en) 2004-07-28
DK1165071T3 (da) 2006-02-20
DE60024243D1 (de) 2005-12-29
ZA200107736B (en) 2003-02-26
JP2007169297A (ja) 2007-07-05
HK1044111A1 (en) 2002-10-11
TWI276434B (en) 2007-03-21
CN1345240A (zh) 2002-04-17
AU3924400A (en) 2000-10-16

Similar Documents

Publication Publication Date Title
NO20021400L (no) Terapeutiske kinazolinderivater
DK1637127T3 (da) Terapeutisk mikroskum
IL152754A0 (en) Quinazoline derivatives for the treatment of tumours
DE69924365D1 (de) Massagegerät
FI20000863A (fi) Uusi hoitomenetelmä
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
AR028476A1 (es) Tratamiento del cancer
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO20020358L (no) Anvendelse av etodolac til behandling av kreft
NO20014725D0 (no) Forbedret kreftbehandling med temozolomid
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
NO20013596D0 (no) Slambehandling
DE60022086D1 (de) Wasserbehandlung
IL149281A0 (en) Treatment of cancer
DE59908327D1 (de) Verformungskörper
SI1165071T1 (sl) Izboljsano zdravljenje raka s temozolomidom
NO20014850D0 (no) CML-terapi
DK1043026T3 (da) Melanombehandling
SE9903421D0 (sv) Behandlingsförfarande
ES1044621Y (es) Tumbona perfeccionada
GB9927106D0 (en) Cancer treatment
GB9908176D0 (en) Cancer treatment
NO995276D0 (no) Behandlingsbenk

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MM1K Lapsed by not paying the annual fees